HPSE and urinary bladder carcinoma: Curiously, Hpa2 expression does not always inhibit heparanase activity, as heparanase activity remained unchanged in pharyngeal carcinoma cells and in bladder carcinoma cells engineered to overexpress Hpa2 (83, 84).